[Article] Trends in Overall and Non-COVID-19 Hospital Admissions

(Kaiser Family Foundation, October 19, 2020)

"Approximately seven months after the coronavirus sparked social distancing measures and concerns about hospital capacity, new medical records data help shed light on the magnitude of the drop in hospital admissions and the more recent rebound in hospitalizations. These new data provide additional information to help assess the economic impact of the COVID-19 pandemic on hospitals and insurers and also provide more information to help assess the extent to which people are still delaying or forgoing care."

Read More ... 


[Article] Advice for Hospital Leaders About the Price Transparency Rule

(HealthLeaders Media, October 20, 2020)

"Hospitals and health systems remain focused on the potential impact of the proposed price transparency rule set to effect in January. Though the policy is currently being appealed in federal court by the American Hospital Association (AHA) and three other hospital associations, the final rule issued by the Centers for Medicare & Medicaid Services (CMS) continues to generate conversation among industry leaders." 

Read More ... 

[Article] Where Have All the Hospital Patients Gone?

(The New York Times, October 20, 2020)

"Except in areas where Covid is surging, there are still no lines of patients in the hospital halls. Some experts have pointed to patients’ overwhelming fear of contagion as a reason for the drop in the numbers seeking hospital care. But in a study by Sound Physicians, the patients who had the greatest persistent drop in hospitalization were those with acutely worsening asthma or emphysema, pneumonias, sepsis, strokes and even heart attacks, all illnesses where hospitalization is generally not optional." 

Read More ...

[Article] Cancer research another long-term casualty of the coronavirus pandemic, scientists say

(NBC News, October 21, 2020)

"The pandemic has caused unprecedented disruptions in medical research for potentially lifesaving cancer treatments. Research projects have been delayed, scientists have had to renegotiate funding deals and cancer charities face huge economic challenges. Even as some trials have returned to normal, experts warn cancer research will be a long-term casualty of the virus." 

Read More ...